PUBLISHER: Inkwood Research | PRODUCT CODE: 1170424
PUBLISHER: Inkwood Research | PRODUCT CODE: 1170424
The Asia-Pacific X-ray tube market is predicted to record a CAGR of 4.35% across the forecast period of 2022 to 2030. The market growth of the region is reinforced by promising trends in the healthcare sector, the surge in population, the adoption of new technologies, and digital transformation.
The Asia-Pacific X-ray tube market growth evaluation covers the thorough assessment of South Korea, Indonesia, China, Japan, India, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific. South Korea's market for medical devices has observed steady growth over recent years. Moreover, South Korea is technologically advanced compared to the majority of other countries in the Asia-Pacific. The nation is also becoming a hub for pharmaceutical manufacturers, with eminent drug manufacturers, such as Novartis and BIAL, increasingly investing in South Korea, given their highly advanced production environments.
Conversely, Indonesia is one of the latest Asian markets in terms of presenting foreign mid and small-sized medical device firms with lucrative opportunities. This is mainly accredited to medical device importation as well as regulatory requirements becoming more transparent over the last few years. Additionally, some of the leading players operating in the country's healthcare sector and subsequently fueling the demand for X-ray tubes include Mayapada Group, Siloam Hospitals, and Sinar Mas Group. Hence, the abovementioned factors are anticipated to contribute to the X-ray tube market growth in the Asia-Pacific during the forecasting period.
Some of the key companies in the market are: Lafco India Scientific Industries, Canon Electron Tubes & Devices Co Ltd, etc.